Support Services

Contact the GPA and MPA Support Line

For more information, call 1-877-317-5179, Monday through Friday, 9am - 8pm ET, visit www.GenentechAccessSolutions.com.

Who We Help What We Offer How To Get Started

Privately insured patients

Patients with self- or employer-paid health plans who are concerned about their co-pay

  • Excluding patients who have a federal, state, or local government-funded health plan (eg, Medicare, Medicare Advantage, Medicaid, TRICARE)
    • Government employees and their dependents are eligible provided the federal, state, or local government does not pay for their health plan
  • Excluding patients who reside or receive treatment in Massachusetts
  • Patients currently receiving assistance from the Genentech® Access to Care Foundation (GATCF) or any other co-pay assistance program are not eligible

RITUXAN EXPERIENCE Program*

Provides a prepaid MasterCard® with up to $4000 to help with Rituxan co-pays within the next 12 months

To enroll or for complete program terms and eligibility requirements:

Privately and publicly insured patients

Patients who are concerned about their co-pay and have the following types of health plans:

  • Self-paid
  • Employer-paid
  • Government-paid (including Medicare, Medicare Advantage, TRICARE)

Referrals to independent, nonprofit organizations (INOs)†

Helps patients apply to INOs that give co-pay or other financial aid to patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis

Uninsured patients or those without coverage for Rituxan

Eligible patients who do not have a health plan or whose health plan does not pay for Rituxan

Genentech® Access to Care Foundation (GATCF)

Gives Rituxan free of charge to patients who meet specific financial, insurance and medical criteria
*
The RITUXAN EXPERIENCE Program is not a benefit plan. This program helps with your co-pay for the Rituxan drug only. It does not pay for other costs related to your visit or infusion. Genentech and Biogen Idec reserve the right to change or end this program. This may be done in whole or in part, without notice, at any time.
†
We cannot guarantee co-pay assistance once you have been referred by Genentech Access Solutions. The INOs to which we refer patients each have their own criteria with regard to eligibility, including financial eligibility. We do not have influence or control the operations of those INOs, but Genentech Access Solutions can help you navigate the process of seeking co-pay assistance by referring you to an appropriate organization and by assisting with the application process.

WHAT IS RITUXAN?

Rituxan® (rituximab) is used with glucocorticoids to treat adults with Granulomatosis with Polyangiitis (GPA) (Wegener's Granulomatosis) and Microscopic Polyangiitis (MPA).

IMPORTANT SAFETY INFORMATION

Rituxan therapy can result in serious side effects, some of which can be life threatening. These include:

  • infusion reactions
  • tumor lysis syndrome (TLS)
  • severe skin and mouth reactions
  • progressive multifocal leukoencephalopathy (PML)

Other serious, potentially life-threatening side effects are:

  • hepatitis B infection that may become active again
  • serious infections
  • heart problems
  • low blood cell counts

Common side effects include infections and infusion reactions.

Before treatment with Rituxan, patients should tell their doctor if they have an infection, including one that will not go away or that keeps coming back.

If patients experience any symptoms or side effects during or after Rituxan treatment, they should seek immediate medical attention.

These are not all of the possible side effects with Rituxan. Tell your doctor about any side effect that bothers you or that does not go away.

Please see full prescribing information, including Medication Guide.

If you have any questions about this information, be sure to discuss them with your doctor.